Roth Capital Initiates Coverage On Trulieve Cannabis with Buy Rating, Announces Price Target of $60

Roth Capital analyst Scott Fortune initiates coverage on Trulieve Cannabis (OTC:TCNNF) with a Buy rating and announces Price Target of $60.